MedPath
Found 4 clinical trials|View Analysis
Sort by:

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Phase 2
Not yet recruiting
Conditions
Melanoma
Brain Metastases
Interventions
First Posted Date
2024-12-03
Last Posted Date
2024-12-03
Lead Sponsor
Stanford University
Target Recruit Count
60
Registration Number
NCT06712927
Locations
🇺🇸

Stanford University, Palo Alto, California, United States

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Phase 2
Not yet recruiting
Conditions
Renal Cell Carcinoma, Clear Cell
Interventions
Drug: Drugs Nivolumab
Drug: Ipilimumab
Drug: BMS-986213 (Relatlimab-Nivolumab FDC)
First Posted Date
2024-11-29
Last Posted Date
2024-12-12
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
15
Registration Number
NCT06708949
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Phase 2
Recruiting
Conditions
Melanoma (Skin)
Interventions
Drug: BMS-986213 (Relatlimab-Nivolumab FDC)
Drug: Nivolumab
Drug: Relatlimab
First Posted Date
2023-01-30
Last Posted Date
2024-10-15
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
30
Registration Number
NCT05704647
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Phase 3
Active, not recruiting
Conditions
Colorectal Neoplasms
Interventions
Drug: Nivolumab-relatlimab FDC
Drug: Regorafenib
Drug: TAS-102
First Posted Date
2022-04-14
Last Posted Date
2025-01-06
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
700
Registration Number
NCT05328908
Locations
🇧🇪

Local Institution - 0120, Leuven, Belgium

🇨🇭

Local Institution - 0057, Aarau, AG, Switzerland

🇧🇪

Local Institution - 0070, Edegem, Belgium

and more 136 locations
© Copyright 2025. All Rights Reserved by MedPath